8-K//Current report
MoonLake Immunotherapeutics 8-K
Accession 0001213900-25-106723
$MLTXCIK 0001821586operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:26 PM ET
Size
557.9 KB
Accession
0001213900-25-106723
Documents
- 8-Kea0264149-8k_moonlake.htmPrimary
CURRENT REPORT
- EX-1.1ea026414901ex1-1_moonlake.htm
UNDERWRITING AGREEMENT, DATED NOVEMBER 5, 2025, BY AND BETWEEN MOONLAKE IMMUNOTHERAPEUTICS AND LEERINK PARTNERS LLC
- EX-5.1ea026414901ex5-1_moonlake.htm
OPINION OF WALKERS (CAYMAN) LLP
- GRAPHICex5-1_001.jpg
GRAPHIC
- EX-101.SCHmltx-20251105.xsd
XBRL SCHEMA FILE
- EX-101.LABmltx-20251105_lab.xml
XBRL LABEL FILE
- EX-101.PREmltx-20251105_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-106723-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0264149-8k_moonlake_htm.xml
IDEA: XBRL DOCUMENT
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001821586
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 5:26 PM ET
- Size
- 557.9 KB